Document Detail


Calcium and colorectal epithelial cell proliferation in ulcerative colitis.
MedLine Citation:
PMID:  9419397     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In persons at higher risk for colon cancer (e.g., those with sporadic adenoma or ulcerative colitis), compared to those at lower risk, colonic epithelial cell proliferation kinetics are altered. We have shown previously that calcium supplementation appears to normalize the distribution of proliferating cells without affecting the proliferation rate in the colorectal mucosa of sporadic adenoma patients. In a pilot randomized, double-blind, placebo-controlled, clinical trial conducted concurrently with our previously published sporadic adenoma trial, we tested whether calcium supplementation can also modulate cell proliferation kinetics in patients with ulcerative colitis. Ulcerative colitis patients (n = 31) were randomized to placebo or 2.0 g of supplemental calcium daily. Colorectal epithelial cell proliferation was determined by immunohistochemical detection of proliferating cell nuclear antigen labeling of cells in "nonprep" rectal biopsies taken at randomization and after 2 months treatment. All biopsies were scored by one reviewer. Differences in mean follow-up minus baseline labeling index (LI; the proportion of colon crypt epithelial cells that were labeled) and in the phi(h) (proportion of labeled cells that were in the upper 40% of the crypts) were compared with analysis of covariance. Pill-taking adherence was 97%. Biopsy-scoring reliability was high (r = 0.89). The pooled baseline LI and phi(h) were 6.3% and 5.6%, respectively. The LI in the calcium group decreased by 0.5% (proportionately, 3%) more than in the placebo group (P = 0.91). Similarly, the phi(h) in the calcium group decreased by 0.3% (proportionately, 10%) more than in the placebo group (P = 0.85). This pilot study does not suggest that 2.0 g of calcium as calcium carbonate daily can substantially normalize either the rate or distribution of proliferating cells over a 2-month period in the colon crypts of patients with ulcerative colitis; a more definitive answer to the question of whether calcium may be effective would require a study with a larger sample size and/or other study design modifications.
Authors:
R M Bostick; M Boldt; M Darif; J R Wood; P Overn; J D Potter
Related Documents :
11761447 - Auricular acupuncture increases cell proliferation in the dentate gyrus of sprague-dawl...
19926617 - Role of a novel bile acid receptor tgr5 in the development of oesophageal adenocarcinoma.
19731267 - Thymidine analog methods for studies of adult neurogenesis are not equally sensitive.
16738477 - Hippocampal cell proliferation regulation by repeated stress and antidepressants.
575287 - Prognostic evaluation of secretory otitis media as a function of mastoidal pneumatisation.
9671277 - Prenatal development of reelin-immunoreactive neurons in the human neocortex.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology     Volume:  6     ISSN:  1055-9965     ISO Abbreviation:  Cancer Epidemiol. Biomarkers Prev.     Publication Date:  1997 Dec 
Date Detail:
Created Date:  1998-01-22     Completed Date:  1998-01-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9200608     Medline TA:  Cancer Epidemiol Biomarkers Prev     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1021-7     Citation Subset:  IM    
Affiliation:
Department of Public Health Sciences-Epidemiology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Calcium, Dietary / metabolism,  therapeutic use*
Cell Division / drug effects,  physiology
Colitis, Ulcerative / complications,  diet therapy*,  pathology
Double-Blind Method
Epithelium / physiology
Female
Humans
Intestinal Mucosa / drug effects,  pathology
Male
Middle Aged
Pilot Projects
Risk Factors
Chemical
Reg. No./Substance:
0/Calcium, Dietary

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic aden...
Next Document:  Dietary iron and recurrence of colorectal adenomas.